Guggenheim adjusted its price target on shares of AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN), increasing it to GBP13,100 from ...

This massive new museum that is opening in the world's wealthiest city will feature remarkable art collections for across the ...

Co Inc (NYSE:MRK) shares, reducing the pharmaceutical giant's price target from $130.00 to $122.00 while reaffirming a Buy rating on the stock. The revision by Guggenheim analyst is primarily due to ...

Marc Guggenheim is auctioning signed Arrow, Legends of Tomorrow, and "Arrowverse" crossover scripts to help fund important ...

NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution ...

Guggenheim analyst Vamil Divan lowered the firm’s price target on Merck (MRK) to $122 from $130 and keeps a Buy rating on the shares. The firm ...

Agentforce was launched in September and already signed up 200 companies to deploy Agentforce as their smarter chatbot. Marc ...

Wyoming’s “What is a Woman Act” to define men and women biologically cleared its first hurdle Wednesday, passing out of a ...

MongoDB stock was higher early Monday after analysts at Guggenheim upgraded their view on the company to a buy rating.